Kari Hagen

Manhattan Psychology Group Joins ARC Health

2 min read

Manhattan Psychology Group Joins ARC Health

ARC Health, a Thurston Group portfolio company, announces the acquisition of Manhattan Psychology Group, PC (MPG), a distinguished...

Read More

Oxford Nanopore and Day Zero Diagnostics Partner to Develop a New Class of Bloodstream Infection Diagnostics

3 min read

Oxford Nanopore and Day Zero Diagnostics Partner to Develop a New Class of Bloodstream Infection Diagnostics

Oxford Nanopore, the company delivering a new generation of nanopore-based molecular sensing technology, and Day Zero Diagnostics (DZD), an...

Read More

Guidance Statement for Mental Health Symptoms of Long COVID Announced by the American Academy of Physical Medicine and Rehabilitation

3 min read

Guidance Statement for Mental Health Symptoms of Long COVID Announced by the American Academy of Physical Medicine and Rehabilitation

Today, the American Academy of Physical Medicine and Rehabilitation (AAPM&R) announced new guidance for diagnosing and treating common...

Read More

Allelica launches the Allelica Precision Server, an on-premises solution for clinical bioinformatics analyses

2 min read

Allelica launches the Allelica Precision Server, an on-premises solution for clinical bioinformatics analyses

Allelica, the leading provider of software tools for clinical bioinformatics, announced the launch of its latest innovation,...

Read More

Ketul J. Patel named to Modern Healthcare’s Top Diversity Leaders List

2 min read

Ketul J. Patel named to Modern Healthcare’s Top Diversity Leaders List

Virginia Mason Franciscan Health (VMFH) is proud to announce that Ketul J. Patel, CEO of VMFH and Division...

Read More

COVID-19 Vaccine Protects Against the Corona Virus in Patients with Celiac Disease

2 min read

COVID-19 Vaccine Protects Against the Corona Virus in Patients with Celiac Disease

A retrospective study undertaken by Maccabi KSM Research in Israel has revealed that the Pfizer COVID-19 vaccine offers the...

Read More

SciTech Readies for First-In-Human Trial with Clinical Supply of ST-001 nanoFenretinide

2 min read

SciTech Readies for First-In-Human Trial with Clinical Supply of ST-001 nanoFenretinide

SciTech announced today that it has successfully manufactured the clinical supply of its lead drug candidate, ST-001...

Read More

Kexing Biopharm 2023 Innovation Forum on Targeted Drug Delivery

2 min read

Kexing Biopharm 2023 Innovation Forum on Targeted Drug Delivery

On September 15, “Kexing Biopharm 2023 Innovation Forum on Targeted Drug Delivery” successfully kicked off. This marks...

Read More

MicuRx receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation for Contezolid and Contezolid acefosamil

2 min read

MicuRx receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation for Contezolid and Contezolid acefosamil

MicuRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies for...

Read More

Antengene Announces Phase I Study of Anti-CD24 Monoclonal Antibody ATG-031

2 min read

Antengene Announces Phase I Study of Anti-CD24 Monoclonal Antibody ATG-031

Antengene Corporation Limited (“Antengene” SEHK: 6996.HK), a leading commercial-stage innovative, global biopharmaceutical company dedicated to discovering, developing,...

Read More